The T cell‐targeting PLGA NPs, loaded with TGF‐β1 inhibitor (SD‐208),[115] suppressed tumor growth and prolonged the survival of tumor‐bearing mice by promoting T cell proliferation and inhibiting TGF‐β1 activity. The gene discussed is TGFB1; the disease is neoplasm.